Roxane Laboratories Overview
- Founded
- 1885
- Status
- Acquired/Merged
- Employees
- 1,360
- Latest Deal Type
- M&A
- Financing Rounds
- 3
Roxane Laboratories General Information
Description
Provider of pharmaceutical products. The company manufactures oral solids (tablets, capsules), oral liquids (solutions, syrups), topical solutions and nasal sprays.
Contact Information
Website
Formerly Known As
Philips Roxane
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- P.O. Box 16532
- Columbus, OH 43216
- United States
Roxane Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Roxane Laboratories‘s full profile, request access.
Request a free trialRoxane Laboratories Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Gerald Wojta | President | ||
| Mark Boudreau | Executive Director, Sales |
Roxane Laboratories Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialRoxane Laboratories Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Roxane Laboratories‘s full profile, request access.
Request a free trial